Neuromodulation for impulsivity and suicidality in Veterans with mildtraumatic brain injury and common co-occurring mental health conditions
Project Number5IK2RX004298-02
Former Number1I02RX004298-01P1
Contact PI/Project LeaderAARONSON, ALEXANDRA LEIGH
Awardee OrganizationEDWARD HINES JR VA HOSPITAL
Description
Abstract Text
This Career Development Award Level 2 (CDA2) represents the candidate’s effort to execute a pilot
study of a novel neuromodulatory treatment for Veteran [social and occupational functioning], impulsivity and
[suicidal ideation] following mild traumatic brain injury (mTBI). The candidate’s first aim will examine the
tolerability, safety and feasibility of frontal pole intermittent theta burst stimulation (iTBS) for Veterans with mild
traumatic brain injury (mTBI), negative urgency impulsivity, [and suicidal ideation]. This is important because
impulsivity, which is exhibited in up to 40% of individuals with TBI, is an independent risk factor for dying by
suicide and is associated with poorer functional outcomes following TBI. Presently, there are no widely
accepted treatment strategies for impulsivity, [suicidal ideation and social and occupational functional deficits]
following TBI. The candidate’s second aim is to determine the effects of frontal pole iTBS on social and
community functioning, negative urgency impulsivity and [suicidal ideation]. This will allow the scientific
community to better understand how frontal pole iTBS treatment impacts [social and community] functioning
and mental health outcomes. Finally, the candidate aims to evaluate whether iTBS improves connectivity
between the VMPFC and limbic system, using resting state functional connectivity MRI. Completing this aim
will allow us to better understand how iTBS affects neural connectivity and whether these changes are related
to functional and mental health outcomes.
This research is critical as suicide is a major issue among Veterans within the VA system. Veterans are
22% more likely to die by suicide than civilians. Veterans with TBI are even more likely to die by suicide than
those without TBI. It is important to create a treatment to prevent unnecessary Veteran deaths while helping
Veterans feel empowered and functional within their communities. [Suicide and TBI are not unique to Veterans,
however. Civilians with TBI are also more likely to die by suicide than those without. Thus, findings from this
research could serve to improve neuropsychiatric care in the civilian sector, as well.] This project serves as a
critical first step in allowing the candidate and her team to develop a biologically-informed treatment strategy
for the many individuals who struggle with mTBI, [social and occupational functional deficits], impulsivity and
[suicidal ideation].
Ultimately, the candidate’s long-term career goal is to become an independent clinical researcher in the
VA system with expertise in TBI, suicidality, neurostimulation and neuroimaging. As such, she will complete a
careful training plan under the mentorship of a strong, multidisciplinary training team involving opportunities for
networking with experts in fields relating to the above research, hands-on training in necessary research skills
and coursework complementary to the research project.
The planned research is significant, innovative, and impactful, as it will be the first pilot study of a new
iTBS treatment paradigm, designed to improve Veteran lives and functional outcomes after mTBI. It will also
strengthen the candidate’s knowledge base and research skills, preparing her for an independent career in
post-TBI rehabilitation research, with expertise in impulsivity, suicidality and neuromodulation.
Public Health Relevance Statement
This proposal is relevant to Veterans because it is the first study of a new treatment to help Veterans struggling
with mild traumatic brain injury (mTBI), impulsivity and [suicidal ideation]. These three conditions have been
shown to be linked [and all are associated with problems functioning]. First, this study will make sure the new
treatment, intermittent theta burst stimulation (iTBS), which involves a high-powered magnet placed directly on
the forehead, is safe and easy for Veterans to tolerate. Second, this project will also test to see if the treatment
improves Veteran community functioning, [lessens suicidal ideation] and lessens impulsivity. Finally, Veterans
enrolled in the study will get brain magnetic resonance imaging (MRI) before and after the treatment to
determine how iTBS changes Veterans’ brain connectivity to make them function better. Completing this
research will improve Veterans’ health through the development of a new treatment for impulsivity and
suicidality following mTBI.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAffectAftercareAreaBehaviorBrainBrain InjuriesCaringCessation of lifeClinicalClinical TrialsCommunitiesDataData AnalysesDevelopmentDouble-Blind MethodElementsEnrollmentEvidence based treatmentExhibitsFeeling suicidalForeheadFoundationsFundingGenerationsGoalsHealthImageImpulsive BehaviorImpulsivityIndividualK-Series Research Career ProgramsKnowledgeLimbic SystemLinkMagnetic Resonance ImagingMediatingMedical RecordsMental DepressionMental HealthMentorsMentorshipMissionNeuronal PlasticityOccupationalOutcomePainParticipantPersonsPhysiciansPhysiologic pulsePilot ProjectsPlayPopulationPrefrontal CortexPublishingRandomizedRecording of previous eventsRehabilitation therapyReportingResearchResearch PersonnelResearch Project GrantsRestRiskRisk FactorsSafetySamplingScientistSelf-Injurious BehaviorSerious Adverse EventSideSuicideSystemTestingTherapeuticTrainingTranscranial magnetic stimulationVeteransbrain magnetic resonance imagingcareerdesigneffective therapyempowermentexperiencefunctional improvementfunctional outcomesimprovedinnovationknowledge basemild traumatic brain injurymultidisciplinaryneuralneuroimagingneurological rehabilitationneuropsychiatryneuroregulationnovelprecision medicinepreventrational designrehabilitation researchresponsesafety and feasibilitysafety testingskillssocialsuicidaltherapy designtreatment strategy
No Sub Projects information available for 5IK2RX004298-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5IK2RX004298-02
Patents
No Patents information available for 5IK2RX004298-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5IK2RX004298-02
Clinical Studies
No Clinical Studies information available for 5IK2RX004298-02
News and More
Related News Releases
No news release information available for 5IK2RX004298-02
History
No Historical information available for 5IK2RX004298-02
Similar Projects
No Similar Projects information available for 5IK2RX004298-02